Abstract: A biomarker for determining Kawasaki disease is identified by lipidomic analysis and mass spectrometry. With the use of the biomarker, we develop and provide a kit and a method capable of directly and objectively determining whether the subject suspected of having Kawasaki disease suffers from Kawasaki disease. A kit for determining Kawasaki disease, the kit including LOX-1 protein and/or part thereof having LAB-binding ability, the protein or part thereof being immobilized on a surface of a base material, is provided.
Type:
Application
Filed:
September 4, 2020
Publication date:
September 15, 2022
Applicants:
FUKUOKA CITY HOSPITAL ORGANIZATION, PREMEDICA INC.